• We use cookies and similar tools to give you the best website experience. By using our site, you accept our Websites Privacy Policy.

If you need help accessing our website, call 855-698-9991

NYU Langone Financial Reports

Increasing patient demand and the consistent delivery of exceptional quality and patient safety outcomes has driven NYU Langone Health’s growth and strong operational performance. For the nine months ended May 31, 2026, the system reported an operating margin of 3.4 percent, with operating revenues of $12.8 billion, up 11.5 percent year-over-year. These figures reflect the strong financial performance of NYU Langone Hospitals, which achieved an operating margin of 7.8 percent, partially offset by the operating losses from the two medical schools. This sustained financial strength supports NYU Langone’s continued investment in clinical care, research, and medical education, most recently demonstrated by the announcement of a future academic medical center campus in Melville, New York.

Compared to the nine months ended May 31, 2025, inpatient discharges increased by 5.5 percent and outpatient visits rose by 9.3 percent, driven primarily by year-over-year increases in ambulatory surgeries, visits to emergency departments, and Perlmutter Cancer Center visits. Beyond volume growth, NYU Langone Hospitals is treating more acute cases, with a case mix index (CMI) of 1.95 as of May 31, 2026, which is up from a CMI of 1.90 as of May 31, 2025.

Patients continue to choose NYU Langone for its streamlined care practices and consistently high standard of care across all locations. For the fourth consecutive year, Vizient Inc. ranked NYU Langone Health as the nation’s top academic medical center. U.S. News & World Report’s 2025–26 rankings further distinguish NYU Langone, ranking more specialties at No. 1 than any other health system in the country. Maintaining operational efficiency, high-quality care, and patient safety remains central to NYU Langone’s long-term financial strategy.

2026 Fiscal Year

Q3 Report
Dates: the nine months ended May 31, 2026, and May 31, 2025
Released: July 27, 2026

Q2 Report
Dates: the six months ended February 28, 2026, and February 28, 2025
Released: April 29, 2026

Q1 Report
Dates: the three months ended November 30, 2025, and November 30, 2024
Released: January 26, 2026

2025 Fiscal Year

Annual Report
Dates: August 31, 2024, to August 31, 2025
Released: November 17, 2025

2024 Fiscal Year

Annual Report
Dates: August 31, 2023, to August 31, 2024
Released: November 18, 2024